Skip to main content

Table 3 ACTS Burdens and Benefits scales - EINSTEIN DVT dataset (all countries): data quality, scaling assumptions, targeting, reliability (N=1336)

From: The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients

 

Data quality

Scaling assumptions

Targeting

Reliability

 

Item missing data (%)a

Possible range (midpoint)

Actual score range

Mean score

SD

CITC

Floor/ceiling effects (%)b

Skewness

Cronbach’s alpha

Test-retestc

Mean IICd

Range IIC

Burden items

            

Q1 Bleeding/vigorous activities

1

1–5

1–5

4.26

1.03

0.50

3/57

−1.41

-

-

-

-

Q2 Bleeding/usual activities

1

1–5

1–5

4.47

0.86

0.50

1/65

−1.79

-

-

-

-

Q3 Bruising

0

1–5

1–5

4.39

0.87

0.45

1/58

−1.49

-

-

-

-

Q4 Avoid other medicines

0

1–5

1–5

4.54

0.80

0.39

1/69

−1.84

-

-

-

-

Q5 Limit eat/drink

0

1–5

1–5

4.55

0.78

0.46

1/69

−1.87

-

-

-

-

Q6 Hassle/daily

0

1–5

1–5

4.41

0.78

0.60

0/56

−1.22

-

-

-

-

Q7 Hassle/occasional

1

1–5

1–5

4.02

0.98

0.57

2/38

−0.85

-

-

-

-

Q8 Difficult to follow your ACT

0

1–5

1–5

4.71

0.58

0.52

0/77

−2.19

-

-

-

-

Q9 Time-consuming ACT

0

1–5

1–5

4.52

0.69

0.43

0/62

−1.40

-

-

-

-

Q10 Worry about ACT

1

1–5

1–5

4.07

0.91

0.56

1/37

−0.84

-

-

-

-

Q11 Frustrating ACT

0

1–5

1–5

4.45

0.87

0.61

1/64

−1.76

-

-

-

-

Q12 Burden of ACT

1

1–5

1–5

4.49

0.75

0.65

0/62

−1.52

-

-

-

-

ACTS Burdens scale

4

12–60 (36)

23–60

52.9

6.1

-

0/11

−1.08

0.85

0.97

0.32

0.13–0.66

Benefit items

            

Q14 Confident in ACT

1

1–5

1–5

3.77

0.91

0.71

3/19

−0.88

-

-

-

-

Q15 Reassured by ACT

1

1–5

1–5

3.71

0.87

0.80

3/15

−0.84

-

-

-

-

Q16 Satisfied with ACT

0

1–5

1–5

3.79

0.90

0.69

3/19

−0.92

-

-

-

-

ACTS Benefits scale

1

3–15 (9)

3–15

11.3

2.4

-

1/10

−0.80

0.86

0.86

0.67

0.59–0.73

  1. aLess than 0.5% missing data rounded to 0. bCalculated as the percentage of people scoring either 12 (floor) or 60 (ceiling) on the ACTS Burdens scale or 3 (floor) or 15 (ceiling) on the ACTS Benefits scale. cTest-retest between two administrations at 12 weeks. dRepresenting homogeneity.
  2. ACT anticoagulation treatment, ACTS Anti-Clot Treatment Scale, CITC corrected item-total correlation, IIC item-item correlation, SD standard deviation, - analyses not conducted owing to lack of data.